Can octreotide prevent post-ERCP pancreatitis?
dc.contributor.buuauthor | Kaya, Ekrem | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-9562-4195 | tr_TR |
dc.contributor.researcherid | AAG-7319-2021 | tr_TR |
dc.contributor.scopusid | 7004568109 | tr_TR |
dc.date.accessioned | 2024-03-01T05:31:52Z | |
dc.date.available | 2024-03-01T05:31:52Z | |
dc.date.issued | 2007-07 | |
dc.identifier.citation | Kaya, E. (2007). "Can octreotide prevent post-ERCP pancreatitis?". American Journal of Gastroenterology, 102(7), 1540-1541. | en_US |
dc.identifier.endpage | 1541 | tr_TR |
dc.identifier.issn | 0002-9270 | |
dc.identifier.issue | 7 | tr_TR |
dc.identifier.pubmed | 17593165 | tr_TR |
dc.identifier.scopus | 2-s2.0-34250858458 | tr_TR |
dc.identifier.startpage | 1540 | tr_TR |
dc.identifier.uri | https://doi.org/10.1111/j.1572-0241.2007.01327.x | |
dc.identifier.uri | https://hdl.handle.net/11452/40109 | |
dc.identifier.volume | 102 | tr_TR |
dc.identifier.wos | 000247474100031 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.journal | Lippincott Williams & Wilkins | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | C-reactive protein | en_US |
dc.subject | Placebo | en_US |
dc.subject | Controlled trial | en_US |
dc.subject | Prophylaxis | en_US |
dc.subject | Multicenter | en_US |
dc.subject | Hyperamylasemia | en_US |
dc.subject | Risk | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject.emtree | Abdominal distension | en_US |
dc.subject.emtree | Abdominal pain | en_US |
dc.subject.emtree | Amylase blood level | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Differential diagnosis | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Endoscopic retrograde cholangiopancreatography | en_US |
dc.subject.emtree | Fever | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hyperamylasemia | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Nausea | en_US |
dc.subject.emtree | Pancreatitis | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Prophylaxis | en_US |
dc.subject.emtree | Randomization | en_US |
dc.subject.emtree | Vomiting | en_US |
dc.subject.emtree | Amylase | en_US |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | Octreotide | en_US |
dc.subject.emtree | Placebo | en_US |
dc.subject.mesh | Bile duct diseases | en_US |
dc.subject.mesh | C-reactive protein | en_US |
dc.subject.mesh | Cholangiopancreatography, endoscopic retrograde | en_US |
dc.subject.mesh | Gastrointestinal agents | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Octreotide | en_US |
dc.subject.mesh | Pancreatitis | en_US |
dc.subject.mesh | Postoperative complications | en_US |
dc.subject.mesh | Severity of illness index | en_US |
dc.subject.mesh | Tomography, x-ray computed | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.title | Can octreotide prevent post-ERCP pancreatitis? | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q1 (Gastroenterology & Hepatology) | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: